Relias Learning acquires Autism Training Solutions

Strategic acquirers — particularly PE-backed consolidators — look primarily for content depth and quality, accreditation credentials, and distribution moats. In the health and human services e-learning space, BACB approval or alignment with bodies like the National Autism Center signals institutional credibility and creates a defensible position that is difficult for generalist competitors to replicate quickly.

Beyond content, acquirers assess whether the target's learning management infrastructure can integrate cleanly with their own platform, and whether the customer base — often enterprise healthcare organisations — will withstand the transition. Low churn, strong Net Revenue Retention (NRR), and regulatory tailwinds are powerful signals.

PE buyers conducting edtech acquisitions typically build their valuation around Annual Recurring Revenue (ARR), content catalogue scale, and completion or engagement rates as a proxy for course quality. For roll-up strategies specifically, the strategic premium paid reflects how well the target's content fills gaps in the platform's existing library — scarcity of accredited, specialist content commands a meaningful uplift over a generic e-learning provider.

Due diligence in this sector also covers intellectual property ownership of all course content, licensing arrangements for third-party materials, and — critically — whether regulatory approvals (such as BACB certification) are held by the company or are personal to an individual instructor.

Behaviour Analyst Certification Board (BACB) approval for continuing education credits is a significant value driver in any acquisition of an Applied Behavioural Analysis (ABA) training business. It signals that the content meets a professional standard recognised by the field's primary credentialing body — meaning courses can satisfy mandatory CPD requirements for certified behaviour analysts and Registered Behaviour Technicians (RBTs).

From an acquirer's perspective, BACB-accredited content is structurally stickier than general training material. For a consolidator like Relias, adding BACB-approved content materially strengthened the enterprise value proposition to its healthcare clients.

Intellectual property is one of the most scrutinised areas in healthcare e-learning acquisitions. Buyers want to confirm that the target owns — not licenses — the core course content, that video footage and clinical expertise referenced in modules are covered by appropriate releases, and that any third-party clinical frameworks or diagnostic tools are used with proper consent.

For specialist providers like ATS, which built content around recognised clinical methodologies, buyers also assess whether the credibility of the content is tied to specific named experts. If courses derive their authority from a founder's personal profile rather than from the company's institutional credentials, that can limit the standalone value of the IP after a change of ownership.

The most common integration risks in healthcare e-learning bolt-on acquisitions are: LMS compatibility (whether the target's course delivery system can be migrated to the acquirer's platform without degrading the learner experience); customer contract continuity (whether institutional licences allow assignment on a change of control); and instructor or founder dependency.

Regulatory complexity is also a factor — particularly where different accreditation bodies apply across geographies. A US-based provider acquired by a UK or European group will need to navigate BACB requirements alongside any equivalent frameworks operating in the new parent's core markets.

This is the question that keeps most purpose-driven founders awake during a sale process — and one that good sell-side M&A advisors must take seriously. The answer depends almost entirely on acquirer selection. A strategic buyer with a complementary mission and the distribution infrastructure to scale the product can genuinely amplify a founder's impact. A purely financial buyer focused on cost reduction can hollow it out.

The Autism Training Solutions case is instructive. Emaley McCulloch's goal was to get quality ABA training to as many practitioners as possible. Relias's scale and LMS infrastructure made that more achievable post-acquisition than it would have been for ATS independently. Founders considering a sale should interrogate the acquirer's track record with prior acquisitions — not just the headline consideration.

UK-based training company founders face several long-term challenges that go beyond the sale itself. Earnout structures — common in the sector because forward revenue is tied to renewal rates — can create significant post-close tension if integration decisions made by the acquirer adversely affect the metrics the deferred consideration is measured against. Founders should negotiate earnout protection clauses that limit the acquirer's ability to change pricing, product packaging, or customer service standards during the earnout period.

A second challenge is regulatory change. UK training companies operating in regulated sectors face ongoing uncertainty about CPD requirements, accreditation frameworks, and government funding schemes. A founder who has exited and is now constrained by non-compete arrangements may find that the sector shifts significantly in the years following their departure, limiting their ability to respond.

US PE-backed acquirers looking at UK edtech targets typically require three things: a clearly articulated regulatory or accreditation moat that creates defensible recurring demand; enterprise customer relationships — institutional licences with NHS trusts, local authorities, or large care groups are far more attractive than individual user subscriptions; and clean, audited financials that allow confident ARR and NRR calculation.

Cross-border deals also introduce additional complexity: HMRC and Companies House filings must be coherent, IP ownership must be unambiguous, and UK GDPR compliance will be scrutinised closely by US buyers increasingly aware of the risks of acquiring businesses with latent compliance exposures. Engaging a UK sell-side M&A advisor with cross-border transaction experience early in the process materially reduces the risk of deals stalling at due diligence. CapEQ advises founders on cross-border exits.

For founders in the autism, SEN, or broader neurodiversity training market, the most important pre-sale preparation steps are: documenting all accreditation credentials and ensuring they are held by the company entity rather than individually; compiling evidence of clinical advisory relationships and content review processes; cleaning up IP assignments to confirm all course content, footage, and assessment frameworks are company-owned; and preparing a clear ARR schedule that distinguishes enterprise (institutional) from individual user revenue.

UK founders should also prepare a regulatory landscape summary — a brief document that maps the company's products to regulatory requirements and explains the regulatory tailwinds driving demand. This two-page strategic overview can significantly sharpen an acquirer's confidence during early-stage conversations and reduce time spent in initial due diligence.

Non-compete clauses in UK edtech transactions typically run for 12 to 24 months post-completion and are usually scoped to the specific market the business operated in — the narrower the scope, the less constraining the clause in practice. In specialist sectors like autism training or clinical e-learning, the definition of the restricted market can be a critical negotiation point: a clause scoped to "health and social care e-learning" will constrain a founder far more broadly than one scoped to "ABA training for BACB-credentialed professionals".

Founders should also plan for the psychological dimension of departure. The transition from running a mission-driven business to a consultancy or employment role within a larger acquirer — even a well-aligned one — is significant. Many founders report that the 12 months immediately post-exit are the most emotionally complex part of the entire process. Working with an advisor who acknowledges that dimension makes a material difference. CapEQ's EQ Difference addresses exactly this.